Filing Flows › Synopsys (SNPS) › R&D spending
Synopsys (SNPS) R&D spending by quarter
Synopsys' R&D spending was $720M in Q3 FY26 (third quarter fiscal 2026), +3% from Q2 FY26. Over the last 7 quarters it ranged from $554M (Q2 FY25) to $747M (Q4 FY25).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 FY26 | $720M | +3% | +15% |
| Q2 FY26 | $700M | -2% | +26% |
| Q1 FY26 | $715M | -4% | — |
| Q4 FY25 | $747M | +19% | +35% |
| Q3 FY25 | $625M | +13% | — |
| Q2 FY25 | $554M | -0.2% | — |
| Q4 FY24 | $555M | — | — |
Q3 FY26 at a glance
Synopsys, Q3 FY26: revenue $2.5B (+42% year over year), operating margin 14.4%, net earnings $546M, operating cash flow $813M. The chart follows the revenue to costs, profit and cash.
Questions
What is Synopsys' R&D spending?
Synopsys' R&D spending was $720M in Q3 FY26 (third quarter fiscal 2026), +3% from Q2 FY26.
How has Synopsys' R&D spending changed?
Over the last 7 quarters it ranged from $554M (Q2 FY25) to $747M (Q4 FY25).